These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1424648)

  • 1. Unpreserved carboxymethylcellulose artificial tears evaluated in patients with keratoconjunctivitis sicca.
    Grene RB; Lankston P; Mordaunt J; Harrold M; Gwon A; Jones R
    Cornea; 1992 Jul; 11(4):294-301. PubMed ID: 1424648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of carboxymethylcellulose vs. hydroxypropyl methylcellulose as a gonioscopic fluid.
    Nguyen TP; Nishimoto JH; Nakamura CY; De Land PN
    Optom Vis Sci; 1996 Jul; 73(7):466-72. PubMed ID: 8843126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a physiological tear substitute in patients with keratoconjunctivitis sicca.
    Nelson JD; Drake MM; Brewer JT; Tuley M
    Adv Exp Med Biol; 1994; 350():453-7. PubMed ID: 8030518
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group.
    Nelson JD; Gordon JF
    Am J Ophthalmol; 1992 Oct; 114(4):441-7. PubMed ID: 1415455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sucralfate and sodium sucrose sulphate in the treatment of superficial corneal disease in keratoconjunctivitis sicca.
    van Bijsterveld OP; van Hemel OL
    Acta Ophthalmol (Copenh); 1992 Aug; 70(4):518-21. PubMed ID: 1414298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca.
    Nelson JD; Farris RL
    Arch Ophthalmol; 1988 Apr; 106(4):484-7. PubMed ID: 2451494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
    Pflugfelder SC; Maskin SL; Anderson B; Chodosh J; Holland EJ; De Paiva CS; Bartels SP; Micuda T; Proskin HM; Vogel R
    Am J Ophthalmol; 2004 Sep; 138(3):444-57. PubMed ID: 15364229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca.
    Iester M; Orsoni GJ; Gamba G; Taffara M; Mangiafico P; Giuffrida S; Rolando M
    Eye (Lond); 2000 Dec; 14(Pt 6):892-8. PubMed ID: 11584850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effect of refresh plus and bion tears on dry eye symptoms and ocular surface health in myopic LASIK patients.
    Albietz JM; Lenton LM; McLennan SG; Earl ML
    CLAO J; 2002 Apr; 28(2):96-100. PubMed ID: 12054380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
    Kaswan RL; Salisbury MA; Ward DA
    Arch Ophthalmol; 1989 Aug; 107(8):1210-6. PubMed ID: 2757551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical performance of a mid-viscosity artificial tear for dry eye treatment.
    Simmons PA; Vehige JG
    Cornea; 2007 Apr; 26(3):294-302. PubMed ID: 17413956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of osmolarity of artificial tear drops on relief of dry eye symptoms: BJ6 and beyond.
    Wright P; Cooper M; Gilvarry AM
    Br J Ophthalmol; 1987 Feb; 71(2):161-4. PubMed ID: 3548809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
    Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
    Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative clinical study of tear substitutes in normal subjects and in patients with keratoconjunctivitis sicca.
    Marner K; Prause JU
    Acta Ophthalmol (Copenh); 1984 Feb; 62(1):91-5. PubMed ID: 6202090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
    Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
    Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Corneal Staining in Patients With Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and Phase 3 Studies.
    Malhotra R; Devries DK; Luchs J; Kabat A; Schechter BA; Shen Lee B; Shettle L; Smyth-Medina R; Ogundele A; Darby C; Bacharach J; Karpecki P
    Cornea; 2019 Oct; 38(10):1259-1265. PubMed ID: 31306284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of corneal and conjunctival metaplasia by impression cytology during the treatment of canine keratoconjunctivitis sicca.
    Radziejewski K; Balicki I; Szadkowski M
    Acta Vet Hung; 2018 Jun; 66(2):189-203. PubMed ID: 29958527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate Effect of 3% Diquafosol Ophthalmic Solution on Tear MUC5AC Concentration and Corneal Wetting Ability in Normal and Experimental Keratoconjunctivitis Sicca Rat Models.
    Choi KE; Song JS; Kang B; Eom Y; Kim HM
    Curr Eye Res; 2017 May; 42(5):666-671. PubMed ID: 27791390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Supplementation With n-6 and n-3 PUFAs Improves Moderate-to-Severe Keratoconjunctivitis Sicca: A Randomized Double-Blind Clinical Trial.
    Sheppard JD; Singh R; McClellan AJ; Weikert MP; Scoper SV; Joly TJ; Whitley WO; Kakkar E; Pflugfelder SC
    Cornea; 2013 Oct; 32(10):1297-304. PubMed ID: 23884332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.